Emergex Vaccines

Emergex Vaccines
Emergex Vaccines
Emergex focuses on developing vaccines that prevent virulent diseases such as Zika, Dengue Fever, Ebola and even pandemic Flu. The company’s set-point vaccines deliver experimentally-derived pathogen peptide data via quantum-sized nanoclusters to prime the immune system to recognise subsequent infections, mimicking natural infection and preventing severe manifestation of the disease. Emergex’s T-cell vaccines elicit different responses than traditional antibody-producing vaccines, eliminating allergic, autoimmune or antibody-mediated side effects.
BioTech, eHealth, Healthcare, Vaccination, Emergex Vaccines, Abingdon

Articles about Emergex Vaccines:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Emergex Vaccines? We’re happy to assist you with our Startup Sourcing service.